Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Zorro

(15,740 posts)
Wed Apr 26, 2017, 09:07 AM Apr 2017

This one unbelievably expensive Iowa patient makes the case for single-payer healthcare

Back in mid-2016, Iowa customers of Wellmark Blue Cross Blue Shield, the dominant company in the state’s individual insurance market, got a shock: Premium increases of 38% to 43% were in store for many of them for this year.

Three weeks ago they got a bigger shock: Wellmark was pulling out of Iowa’s individual market entirely, leaving the state with one company selling individual policies. Wellmark placed some of the blame on congressional Republicans’ failure to come up with a coherent repeal plan for the Affordable Care Act, leaving plans for 2018 in legislative limbo. With Wellmark’s departure, Iowa’s individual market may be down to a single insurer next year.

But Iowa has another problem that appears to be unique for a state its size: one single state resident whose care costs $1 million a month. That’s enough to all but destroy an individual insurance market that comprises about 30,000 customers. Indeed, that one patient’s care, according to Wellmark, was responsible for 10 percentage points of the 43% premium increase this year.

The patient has not been identified; nor has his or her medical condition, beyond a statement by Wellmark that he or she suffers from a complicated and severe genetic disorder. Speculation in the healthcare industry about the reasons for the expense focuses on the cost of the patient’s medications.

http://www.latimes.com/business/hiltzik/la-fi-hiltzik-iowa-20170424-story.html

5 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies

Calista241

(5,586 posts)
4. Good luck. Publishing this patients specific treatment regimen would be a serious
Wed Apr 26, 2017, 09:53 AM
Apr 2017

HIPPA violation. Whether anything personally identifiable was released or not.

Tom Rinaldo

(22,912 posts)
2. "...the reasons for the expense focuses on the cost of the patients medications"
Wed Apr 26, 2017, 09:41 AM
Apr 2017

OK, that's speculation on their part but well founded. Again, drug prices, and again Congress opposes any efforts to allow any government agency to negotiate with drug companies about drug prices unlike virtually everywhere else in the world, insuring that Americans always pay the highest prices on Earth for medications

Latest Discussions»General Discussion»This one unbelievably exp...